| 1. |
Wang M, Garg I, Miller JB. Wide field swept source optical coherence tomography angiography for the evaluation of proliferative diabetic retinopathy and associated lesions: a review[J]. Semin Ophthalmol, 2021, 36(4): 162-167. DOI: 10.1080/08820538.2021.1887901.
|
| 2. |
Zhang T, Wang Z, Sun L, et al. Ultra-wide-field scanning laser ophthalmoscopy and optical coherence tomography in FEVR: findings and its diagnostic ability[J]. Br J Ophthalmol, 2021, 105(7): 995-1001. DOI: 10.1136/bjophthalmol-2020-316226.
|
| 3. |
Luvisi JR, Blair K. Familial exudative vitreoretinopathy (FEVR)[M/OL]. Treasure Island (FL): StatPearls Publishing, 2026. https://www.ncbi.nlm.nih.gov/books/NBK614159/?report=printable.
|
| 4. |
Xu N, Cai Y, Li J, et al. An SNX31 variant underlies dominant familial exudative vitreoretinopathy-like pathogenesis[J/OL]. JCI Insight, 2023, 8(10): e167032[2023-05-22]. https://pubmed.ncbi.nlm.nih.gov/37053012/. DOI: 10.1172/jci.insight.167032.
|
| 5. |
Yonekawa Y, Thomas BJ, Drenser KA, et al. Familial exudative vitreoretinopathy: spectral-domain optical coherence tomography of the vitreoretinal interface, retina, and choroid[J]. Ophthalmology, 2015, 122(11): 2270-2277. DOI: 10.1016/j.ophtha.2015.07.024.
|
| 6. |
Tauqeer Z, Yonekawa Y. Familial exudative vitreoretinopathy: pathophysiology, diagnosis, and management[J]. Asia Pac J Ophthalmol (Phila), 2018, 7(3): 176-182. DOI: 10.22608/APO.201855.
|
| 7. |
Wang Z, Liu CH, Sun Y, et al. Pharmacologic activation of Wnt signaling by lithium normalizes retinal vasculature in a murine model of familial exudative vitreoretinopathy[J]. Am J Pathol, 2016, 186(10): 2588-2600. DOI: 10.1016/j.ajpath.2016.06.015.
|
| 8. |
Joussen AM, Gordes RS, Heu?en FA, et al. Retinal exudative disease in childhood: Coats' disease and familial exudative vitreoretinopathy (FEVR)[J]. Klin Monbl Augenheilkd, 2013, 230(9): 902-913. DOI: 10.1055/s-0033-1350689.
|
| 9. |
Agrawal V, Kalia S. Management and surgical outcomes of pediatric retinal detachment associated with familial exudative vitreoretinopathy-our experience at a tertiary care ophthalmic center in North India[J]. Indian J Ophthalmol, 2022, 70(7): 2490-2496. DOI: 10.4103/ijo.IJO_2292_21.
|